DRDx to Drdx Home


News


Bonn, 29. January, 2014

Drug Response Dx GmbH is presenting at the Theragnostics-Workshop of the High-Tech Partnering Conference

Drug Response Dx GmbH is presenting at the Theragnostics-Workshop of the High-Tech Partnering Conference am 29. January 2014 in Bonn, Germany. For more information on the conference please visit the site of the High-Tech Gründerfond:

more (in German)

Dubai, 27. – 30. January, 2014

The Drug Response Dx GmbH is represented on the Arab Health 2014
Arabhealth Logo


The Drug Response Dx GmbH is represented on the Arab Health 2014 at the Dubai International Convention & Exhibition Centre. Come and see us at the DiagnostikNet BB e.V. stand (Rashid Hall, RJ14) and ask for Dr. Jörg-M. Hollidt.

For more Information see:
Dubai International Convention & Exhibition Centre

Bernau, May 22.-23., 2013

Dr. Zoltán Konthur presents Individualized Therapies in Rheumatoid Arthritis at the “15. Bernauer Autoimmuntage” in Bernau, Germany.


Hennigsdorf / Bonn / Hilden, January 7, 2013

Drug Rsponse Dx attracts first investment

The Hennigsdorf firm Drug Response Dx GmbH (DRDx GmbH) successfully concluded its first round of financing with High-Tech Gründerfonds and QIAGEN.
The investment will serve to develop a biomarker test kit for rheumatoid arthritis treatment guidance with so-called TNF-alpha inhibitors. The test is secured by a unique patent platform exclusively in-licensed by the Max Planck Society.

more more (in German)

News – Press – Events


29. January, 2014

Drug Response Dx GmbH is presenting at the Theragnostics-Workshop of the High-Tech Partnering Conference

more

27. – 30. January, 2014

The Drug Response Dx GmbH is represented on the Arab Health 2014 at the Dubai

more

11. December, 2013

Drug Response Dx GmbH has been certified